Shamburg News · 8-K filed Oct 26, 2026, 4:53 PM EDT

Rallybio Declares Estimated $13.56 Per Share Special Cash Distribution Tied to Avenzo Merger

RLYB · Rallybio Corp

  • Dividend
  • Acquisition
  • Other event
  • Materiality: high

On October 25, 2026, Rallybio Corporation's board declared a special cash distribution tied to its merger with Avenzo Therapeutics, estimated at $82.7 million, or $13.56 per share. The distribution is payable to stockholders and pre-funded warrant holders of record as of November 5, 2026, with payment scheduled for November 13, 2026, and is conditioned on stockholder approval at the November 4, 2026 annual meeting. The company expects Nasdaq to set November 6, 2026 as the ex-dividend date, with a due bill period from November 4 through November 6, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001193125-26-432114.

Written from the filing by Shamburg Markets. Figures are as reported by the company.